Umbilical Cord-derived Mesenchymal Stem Cell therapy(National Engineering Center of Cell Products)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameUmbilical Cord-derived Mesenchymal Stem Cell therapy(National Engineering Center of Cell Products)

Drug Alias NameMesenchymal Stem Cells (Umbilical Cord)therapy(National Engineering Center of Cell Products)

ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsIschemic StrokeAcute-On-Chronic Liver Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesNational Engineering Center of Cell Products

China Registration ClassN/A

Develop Information

Active CompaniesNational Engineering Center of Cell Products

Inactive CompaniesN/A

Active IndicationsIschemic StrokeAcute-On-Chronic Liver Failure

Inactive IndicationsN/A

Other Information

ATC CodeN/A